Stifel Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.25M | Buy |
|
|||||
|
2025
Q2 | $4.47M | Buy |
|
|||||
|
2025
Q1 | $1.91M | Sell |
|
|||||
|
2024
Q4 | $2.36M | Buy |
|
|||||
|
2024
Q3 | $1.6M | Sell |
|
|||||
|
2024
Q2 | $1.44M | Sell |
|
|||||
|
2024
Q1 | $1.25M | Sell |
|
|||||
|
2023
Q4 | $2.23M | Buy |
|
|||||
|
2023
Q3 | $1.43M | Sell |
|
|||||
|
2023
Q2 | $1.77M | Buy |
|
|||||
|
2023
Q1 | $1.54M | Buy |
|
|||||
|
2022
Q4 | $1.77M | Sell |
|
|||||
|
2022
Q3 | $2.05M | Buy |
|
|||||
|
2022
Q2 | $1.4M | Sell |
|
|||||
|
2022
Q1 | $1.99M | Sell |
|
|||||
|
2021
Q4 | $2.49M | Buy |
|
|||||
|
2021
Q3 | $2.64M | Sell |
|
|||||
|
2021
Q2 | $3.86M | Buy |
|
|||||
|
2021
Q1 | $2.86M | Buy |
|
|||||
|
2020
Q4 | $2.08M | Buy |
|
|||||
|
2020
Q3 | $2.14M | Buy |
|
|||||
|
2020
Q2 | $1.99M | Buy |
|
|||||
|
2020
Q1 | $689K | Buy |
|
|||||
|
2019
Q4 | $539K | Buy |
|
|||||
|
2019
Q3 | $328K | Buy |
|
|||||
|
2019
Q2 | $288K | Buy |
|
|||||
|
2019
Q1 | $232K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $456K | Buy |
|
|||||
|
2015
Q1 | $379K | Buy |
|